These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30179738)
1. Time-dependent effects on small intestinal transport by absorption-modifying excipients. Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H Eur J Pharm Biopharm; 2018 Nov; 132():19-28. PubMed ID: 30179738 [TBL] [Abstract][Full Text] [Related]
2. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport. Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302 [TBL] [Abstract][Full Text] [Related]
3. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs. Dahlgren D; Roos C; Johansson P; Tannergren C; Lundqvist A; Langguth P; Sjöblom M; Sjögren E; Lennernäs H Int J Pharm; 2018 Aug; 547(1-2):158-168. PubMed ID: 29758344 [TBL] [Abstract][Full Text] [Related]
4. Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker Dahlgren D; Roos C; Lundqvist A; Tannergren C; Langguth P; Sjöblom M; Sjögren E; Lennernäs H Mol Pharm; 2017 Dec; 14(12):4243-4251. PubMed ID: 28737406 [TBL] [Abstract][Full Text] [Related]
5. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions. Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752 [TBL] [Abstract][Full Text] [Related]
6. Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats. Dahlgren D; Olander T; Sjöblom M; Hedeland M; Lennernäs H Acta Pharm Sin B; 2021 Jun; 11(6):1667-1675. PubMed ID: 34221875 [TBL] [Abstract][Full Text] [Related]
7. Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations. Dahlgren D; Sjöblom M; Lennernäs H Eur J Pharm Biopharm; 2019 Sep; 142():411-420. PubMed ID: 31306749 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model. Dahlgren D; Roos C; Peters K; Lundqvist A; Tannergren C; Sjögren E; Sjöblom M; Lennernäs H Eur J Pharm Biopharm; 2019 Sep; 142():31-37. PubMed ID: 31201856 [TBL] [Abstract][Full Text] [Related]
9. Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Dahlgren D; Cano-Cebrián MJ; Olander T; Hedeland M; Sjöblom M; Lennernäs H Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32182653 [TBL] [Abstract][Full Text] [Related]
10. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside. Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081 [TBL] [Abstract][Full Text] [Related]
11. Effect of permeability enhancers on paracellular permeability of acyclovir. Ates M; Kaynak MS; Sahin S J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718 [TBL] [Abstract][Full Text] [Related]
12. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
13. Regulation of drug absorption from small intestine by enteric nervous system I: a poorly absorbable drug via passive diffusion. Higaki K; Sone M; Ogawara K; Kimura T Drug Metab Pharmacokinet; 2004 Jun; 19(3):198-205. PubMed ID: 15499187 [TBL] [Abstract][Full Text] [Related]
14. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2. Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412 [TBL] [Abstract][Full Text] [Related]
15. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937 [TBL] [Abstract][Full Text] [Related]
16. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers. Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662 [TBL] [Abstract][Full Text] [Related]
17. A kinetic approach to the study of absorption of solutes by isolated perfused small intestine. Fisher RB; Gardner ML J Physiol; 1974 Aug; 241(1):211-34. PubMed ID: 4422346 [TBL] [Abstract][Full Text] [Related]
18. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395 [TBL] [Abstract][Full Text] [Related]
19. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions. Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157 [TBL] [Abstract][Full Text] [Related]
20. Absorptive profile of chlorogenic acid in rats. Ren J; Jiang X; Li C; Li K; Chen Z; Ma G Pharmazie; 2007 Sep; 62(9):689-92. PubMed ID: 17944323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]